These results suggested that STING played a key role in COPA mutation-induced immune disorders, mainly by promoting the differentiation of effector T cells, which indicated that we could develop effective STING pathway inhibitors to treat COPA symptoms. This evidence concerns the gene STING1 and immune system disorder.